Back to News
Market Impact: 0.6

S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges

METAMRNACMGEMEEBAYCHRWCAH
Corporate EarningsCorporate Guidance & OutlookArtificial IntelligenceHealthcare & BiotechM&A & RestructuringCompany FundamentalsConsumer Demand & RetailMonetary Policy
S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges

U.S. equities saw declines as Meta Platforms (META) shares dropped 11.3% following a $16 billion tax charge and increased concerns over accelerating AI-related capital expenditures for 2025. In contrast, Moderna (MRNA) surged 13.9% on reports of strategic talks with a major pharmaceutical company regarding a potential partnership or buyout, as its COVID-19 vaccine sales taper. This divergence highlights investor focus on future growth drivers and cost management amid broader market pressures.

Analysis

U.S. equities experienced a broad decline, with the S&P 500 falling 1% and the Nasdaq 1.6% lower, driven by mixed earnings and macroeconomic concerns. Meta Platforms (META) shares tumbled 11.3% after reporting a significant $16 billion one-time tax charge and projecting "significantly faster" AI-related expense growth for 2025, raising capital expenditure concerns. Chipotle (CMG) also saw an 18.2% drop due to lower-than-expected revenue and reduced full-year guidance, citing a decline in key younger customer demographics amid a challenging macroeconomic environment. In contrast, Moderna (MRNA) surged 13.9% on reports of potential strategic negotiations with a major pharmaceutical company for a partnership or buyout, offering a potential solution to tapering COVID-19 vaccine sales. C.H. Robinson Worldwide (CHRW) led S&P 500 gains, up 19.7%, by leveraging AI for process automation, which resulted in a significant year-over-year reduction in operating expenses and employee headcount. Cardinal Health (CAH) also rose 15.4% after beating Q1 FY26 estimates and raising full-year forecasts, benefiting from robust demand for high-margin specialty and branded drugs. The day's trading highlighted divergent impacts of artificial intelligence, with Meta facing cost pressures while C.H. Robinson demonstrated AI-driven efficiency gains. Broader market sentiment remained cautious following a Federal Reserve rate cut and geopolitical discussions, with consumer demand showing fragility in sectors like fast-casual dining. M&A speculation, as seen with Moderna, continues to be a significant catalyst for individual stock performance amidst sector-specific challenges.